News Headlines Article

Prisons balk at Sovaldi’s $84,000 cost for hepatitis C treatment
San Francisco Chronicle

In San Francisco’s jails, no inmates with hepatitis C are receiving Sovaldi, the breakthrough pill that can cure most patients in an unprecedented amount of time. In California’s prisons, the drug, made by Gilead Sciences of Foster City, is being given to less than 1 percent of the 17,000 inmates with the virus. Sovaldi could wipe out what has long been an intractable disease. But its $84,000 cost for a 12-week supply doesn’t fit into lean government budgets.

Commands